Open Access
Open access
volume 271 issue 22 pages 12687-12690

Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family

Robert M Pitti 1
SCOT A. MARSTERS 1
SIEGFRIED RUPPERT 2
Christopher J Donahue 3
Alison Moore 4
Avi Ashkenazi 1
1
 
Departments of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080-4990
2
 
Departments of Molecular Biology, Genentech, Inc., South San Francisco, California 94080-4990
3
 
Departments of Immunology, and Genentech, Inc., South San Francisco, California 94080-4990
4
 
Departments of Cell Biology, Genentech, Inc., South San Francisco, California 94080-4990
Publication typeJournal Article
Publication date1996-05-01
scimago Q1
wos Q2
SJR1.705
CiteScore7.6
Impact factor3.9
ISSN00219258, 1083351X
Biochemistry
Molecular Biology
Cell Biology
Abstract
Cytokines in the tumor necrosis factor (TNF) family regulate development and function of the immune system. We have isolated a new member of this family, designated Apo-2 ligand (Apo-2L), via an expressed sequence tag. Apo-2L is a 281-amino acid protein, related most closely to Fas/Apo-1 ligand. Transfected Apo-2L is expressed at the cell surface with its C terminus exposed, indicating a type II transmembrane protein topology. Like Fas/Apo-1 ligand and TNF, the C-terminal extracellular region of Apo-2L (amino acids 114-281) exhibits a homotrimeric subunit structure. Soluble Apo-2L induces extensive apoptosis in lymphoid as well as non-lymphoid tumor cell lines. The effect of Apo-2L is not inhibited by soluble Fas/Apo-1 and TNF receptors; moreover, expression of human Fas/Apo-1 in mouse fibroblasts, which confers sensitivity to induction of apoptosis by agonistic anti-Fas/Apo-1 antibody, does not confer sensitivity to Apo-2L. Hence, Apo-2L acts via a receptor which is distinct from Fas/Apo-1 and TNF receptors. These results suggest that, along with other family members such as Fas/Apo-1 ligand and TNF, Apo-2L may serve as an extracellular signal that triggers programmed cell death.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
45
50
Journal of Biological Chemistry
47 publications, 3.27%
Journal of Immunology
41 publications, 2.85%
Oncogene
39 publications, 2.71%
Biochemical and Biophysical Research Communications
24 publications, 1.67%
Blood
24 publications, 1.67%
Cell Death and Differentiation
22 publications, 1.53%
Cancer Research
20 publications, 1.39%
Cancer Letters
17 publications, 1.18%
Oncotarget
16 publications, 1.11%
Molecular Cancer Therapeutics
16 publications, 1.11%
British Journal of Cancer
15 publications, 1.04%
PLoS ONE
14 publications, 0.97%
Cell Death and Disease
13 publications, 0.9%
Cancers
13 publications, 0.9%
International Journal of Molecular Sciences
13 publications, 0.9%
Cancer Gene Therapy
13 publications, 0.9%
International Journal of Cancer
13 publications, 0.9%
Vitamins and Hormones
13 publications, 0.9%
Clinical Cancer Research
13 publications, 0.9%
Journal of Experimental Medicine
12 publications, 0.84%
Journal of Cellular Biochemistry
11 publications, 0.77%
FEBS Letters
10 publications, 0.7%
Oncology Reports
9 publications, 0.63%
Cell Research
9 publications, 0.63%
Apoptosis : an international journal on programmed cell death
9 publications, 0.63%
Cancer Biology and Therapy
9 publications, 0.63%
Current Biology
8 publications, 0.56%
Immunity
8 publications, 0.56%
Scientific Reports
8 publications, 0.56%
5
10
15
20
25
30
35
40
45
50

Publishers

50
100
150
200
250
300
350
Elsevier
345 publications, 24.01%
Springer Nature
305 publications, 21.22%
Wiley
168 publications, 11.69%
American Association for Cancer Research (AACR)
58 publications, 4.04%
Taylor & Francis
55 publications, 3.83%
MDPI
50 publications, 3.48%
American Society for Biochemistry and Molecular Biology
47 publications, 3.27%
The American Association of Immunologists
42 publications, 2.92%
Ovid Technologies (Wolters Kluwer Health)
26 publications, 1.81%
American Society of Hematology
24 publications, 1.67%
Spandidos Publications
23 publications, 1.6%
Mary Ann Liebert
17 publications, 1.18%
Impact Journals
16 publications, 1.11%
SAGE
15 publications, 1.04%
Public Library of Science (PLoS)
14 publications, 0.97%
Frontiers Media S.A.
14 publications, 0.97%
Rockefeller University Press
13 publications, 0.9%
American Society for Microbiology
12 publications, 0.84%
American Chemical Society (ACS)
10 publications, 0.7%
Oxford University Press
10 publications, 0.7%
S. Karger AG
8 publications, 0.56%
Hindawi Limited
8 publications, 0.56%
American Association for the Advancement of Science (AAAS)
7 publications, 0.49%
IMR Press
7 publications, 0.49%
American Society for Pharmacology and Experimental Therapeutics
5 publications, 0.35%
Royal Society of Chemistry (RSC)
5 publications, 0.35%
American Society of Clinical Oncology (ASCO)
5 publications, 0.35%
Portland Press
4 publications, 0.28%
Journal of Neurosurgery Publishing Group (JNSPG)
4 publications, 0.28%
50
100
150
200
250
300
350
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.4k
Share
Cite this
GOST |
Cite this
GOST Copy
Pitti R. M. et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family // Journal of Biological Chemistry. 1996. Vol. 271. No. 22. pp. 12687-12690.
GOST all authors (up to 50) Copy
Pitti R. M., MARSTERS S. A., RUPPERT S., Donahue C. J., Moore A., Ashkenazi A. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family // Journal of Biological Chemistry. 1996. Vol. 271. No. 22. pp. 12687-12690.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1074/jbc.271.22.12687
UR - https://doi.org/10.1074/jbc.271.22.12687
TI - Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
T2 - Journal of Biological Chemistry
AU - Pitti, Robert M
AU - MARSTERS, SCOT A.
AU - RUPPERT, SIEGFRIED
AU - Donahue, Christopher J
AU - Moore, Alison
AU - Ashkenazi, Avi
PY - 1996
DA - 1996/05/01
PB - American Society for Biochemistry and Molecular Biology
SP - 12687-12690
IS - 22
VL - 271
PMID - 8663110
SN - 0021-9258
SN - 1083-351X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1996_Pitti,
author = {Robert M Pitti and SCOT A. MARSTERS and SIEGFRIED RUPPERT and Christopher J Donahue and Alison Moore and Avi Ashkenazi},
title = {Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family},
journal = {Journal of Biological Chemistry},
year = {1996},
volume = {271},
publisher = {American Society for Biochemistry and Molecular Biology},
month = {may},
url = {https://doi.org/10.1074/jbc.271.22.12687},
number = {22},
pages = {12687--12690},
doi = {10.1074/jbc.271.22.12687}
}
MLA
Cite this
MLA Copy
Pitti, Robert M., et al. “Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family.” Journal of Biological Chemistry, vol. 271, no. 22, May. 1996, pp. 12687-12690. https://doi.org/10.1074/jbc.271.22.12687.